PDF-19 March 2013EMA/129698/2012Human Medicines Development and Evaluation
Author : trish-goza | Published Date : 2016-06-03
Agreed by Biostatistic Working Partyay 2012 Agreed by PK Working Party30 May 2012 Agreed by COMP10 May 2012 Adoption by PDCO 16 May Adoption by CHMP 24 May 2012 Start
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "19 March 2013EMA/129698/2012Human Medici..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
19 March 2013EMA/129698/2012Human Medicines Development and Evaluation: Transcript
Agreed by Biostatistic Working Partyay 2012 Agreed by PK Working Party30 May 2012 Agreed by COMP10 May 2012 Adoption by PDCO 16 May Adoption by CHMP 24 May 2012 Start of public consultation29 June 20. Concept and Process. IPC Meeting. June 6, 2014 – WHO Geneva. Nicola Magrini – WHO, EMP. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Concept/Process and Update on EML 2015. WHO Technical Briefing Seminar. Nicola Magrini – WHO, EMP. November 4, 2014 – WHO Geneva. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . Dr Jane Robertson. Policy, Access and Use Team, EMP. 4 November 2014. Appropriate use of medicines. Relies on a number of elements. Availability. , . affordability, and use in practice of effective medicines. Herbal preparations . could . be regarded as the original biologic approach to medicine.. Herbal medicines can be applied to the treatment of a variety of ailments, . including both . acute and chronic . CPS Questions 1-2 . Chapter 4, Lesson 1. Chapter Overview. Lesson 1: Medicines and Drugs. Lesson 2: Tobacco. Lesson 3: Alcohol. Lesson 4: Environmental Health. Chapter 4, Lesson 1. Lesson Overview. How medicines differ from drugs. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Medicines Manufacturing in the UK 2017. Welcome by Andy Evans. Chair, MMIP. Site Lead, AZ Macclesfield. Morning Agenda. 10:00. Introduction. Steve. Thompson ABPI. Steve Bates BIA. Sue Dunkerton KTN. how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament . . Associate Professor Nicole Pratt . Quality use of medicines and pharmacy research centre. University of South Australia. overview. Biologic medicines, or immune based therapies, are a rapidly evolving group of pharmaceutical products whose active component is biologically derived rather than chemically synthesised. . Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...
Download Document
Here is the link to download the presentation.
"19 March 2013EMA/129698/2012Human Medicines Development and Evaluation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents